Randomized, Double-Blinded, Placebo Controlled Study of the Effects of Tolcapone and Entacapone on Cognitive Function in Patients With Schizophrenia and Normal Controls Based on COMT Genotype
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Tolcapone (Primary) ; Entacapone
- Indications Schizophrenia
- Focus Pharmacodynamics; Pharmacogenomic
- 16 Dec 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 10 Oct 2014 Planned End Date changed from 1 Nov 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov record.
- 11 Jan 2014 Planned End Date changed from 1 Nov 2013 to 1 Nov 2015 as reported by ClinicalTrials.gov record.